Cost of treating HIV remains high; Louisiana feels the pain
Tags: MEDICAL care costs; HIV infections; CHEMOTHERAPY
Related Articles
- Financing Health Care for Persons with HIV Infection: Guidelines for State Action. Fox, Daniel M. // American Journal of Law & Medicine;1990, Vol. 16 Issue 1/2, p223
Promises of confidentiality of HIV-related medical records and protection from discrimination based on HIV seropositivity are two of the legislative inducements state governments have offered to encourage voluntary HIV testing. Yet neither can be granted without impact on others whose interests...
- Budget Impact of Medicaid Section 1115 Demonstrations for Early HIV Treatment. Schackman, Bruce R.; Freedberg, Kenneth A.; Goldie, Sue J.; Weinstein, Milton C.; Swartz, Katherine // Health Care Financing Review;Summer2005, Vol. 26 Issue 4, p67
A state-transition model of HIV disease was used to project the costs to Medicaid, Medicare, and AIDS Drug Assistance Programs of proposed Section 1115 Medicaid demonstration projects for the early treatment of HIV-infected patients in Georgia and Massachusetts. Neither demonstration project was...
- Evolution of Antiretroviral Drug Costs in Brazil in the Context of Free and Universal Access to AIDS Treatment. Nunn, Amy S.; Fonseca, Elize M.; Bastos, Francisco I.; Gruskin, Sofia; Salomon, Joshua A. // PLoS Medicine;Nov2007, Vol. 4 Issue 11, pe305
Amy Nunn and colleagues analyze the cost of antiretroviral drugs in Brazil between 2001 and 2005 and discuss the implications for HIV treatment in other developing countries.
- Coping with the cost burdens of illness: Combining qualitative and quantitative methods in longitudinal, household research. Goudge, Jane; Gumede, Tebogo; Gilson, Lucy; Russell, Steve; Tollman, Stephen M.; Mills, Anne // Scandinavian Journal of Public Health;May2007 Supplement 69, Vol. 35, p181
Over the last 10-15 years, poor African households have had to cope with the burden of increased levels of chronic illness such as HIV/AIDS. How do these households cope with the cost burdens of ill health and healthcare, and has this burden further impoverished them? What policy responses might...
- Higher drug costs lowers the overall costs for inner-city AIDS program, study finds. // Formulary;Feb99, Vol. 34 Issue 2, p165
Focuses on a Baltimore, Maryland HIV treatment study which found that three-drug regimens containing a protease inhibitor and one- and two-drug regimens without a protease inhibitor have similar overall costs. Charges for acute and chronic inpatient care; Outpatient care; Drug prescriptions;...
- HIV patients live years after diagnosis. // Gay & Lesbian Times;11/16/2006, Issue 986, p28
The article reports on the results of a research which show that an American diagnosed with the AIDS virus can expect to live for about 24 years on average. The research also shows that the cost of health care throughout those decades is more than $600,000. Bruce Schackman is the lead author of...
- Analysis of Michigan Medicaid Costs to Treat HIV Infection. Solomon, David J.; Hogan, Andrew J.; Bouknight, Reynard A.; Solomon, Carolyn T. // Public Health Reports;Sep/Oct89, Vol. 104 Issue 5, p416
To obtain better understanding of the nature and cost of health care related to human immunodeficiency virus (HIV) infection, medical payment records were analyzed for 204 men, women, and children older than 60 months who had indications of HIV infection. The records were those of Michigan...
- Cost-Effectiveness of Early Treatment with First-Line NNRTI-Based HAART Regimens in the UK, 1996-2006. Beck, Eduard J.; Mandalia, Sundhiya; Lo, Gary; Sharott, Peter; Youle, Mike; Anderson, Jane; Baily, Guy; Brettle, Ray; Fisher, Martin; Gompels, Mark; Kinghorn, George; Johnson, Margaret; McCarron, Brendan; Pozniak, Anton; Tang, Alan; Walsh, John; White, David; Williams, Ian; Gazzard, Brian // PLoS ONE;2011, Vol. 6 Issue 5, p1
Background: Population costs for HIV services are increasing in the UK and interventions need to be effective and efficient to reduce or stabilize costs. 2NRTIs + NNRTI regimens are cost-effective regimens for first-line HAART, but these regimens have not been compared with first-line...
- The Changing Natural History of HIV Disease: Before and After the Introduction of Generic Antiretroviral Therapy in Southern India. Kumarasamy, N.; Solomon, Suniti; Chaguturu, Sreekanth K.; Cecelia, Anitha J.; Vallabhaneni, Snigdha; Flanigan, Timothy P.; Mayer, Kenneth H. // Clinical Infectious Diseases;11/15/2005, Vol. 41 Issue 10, p1525
The article focuses on the changing natural history of human immunodeficiency virus (HIV) infections before and after the introduction of generic antiretroviral therapy in India. The number of individuals seeking treatment for infection with HIV increased as the cost of highly active...
